The Latest Cardiac and Vascular News
Submitted a New Drug Application to the U.S. Food and Drug Administration for the review of tenapanor as a first-in-class therapy to control serum phosphorus in adult patients with chronic kidney disease on dialysis Maintains strong balance sheet with $204.8 million in cash, cash equivalents and short-term investments FREMONT, Calif., Aug. […]
WYNNEWOOD, Pa., Aug. 6, 2020 /PRNewswire/ — Lankenau Heart Institute, part of Main Line Health, has named Basel Ramlawi, MD, the System Chief of Cardiac Surgery for Main Line Health and co-director of the Lankenau Heart Institute. Dr. Ramlawi brings nearly 20 years of complex and minimally invasive cardiovascular surgical experience to his new […]
CARLSBAD, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (NASDAQ: AFIB) today announced the pricing of its initial public offering of 8,823,529 shares of its common stock at a price to the public of $18.00 per share. All of the shares are being offered by Acutus. The […]
– As reported, revenues of $3.855 billion decreased 11.4 percent – On a currency-neutral basis, revenues decreased 9.4 percent – As reported, diluted earnings per share of $0.97 decreased 35.8 percent – As adjusted, diluted earnings per share of $2.20 decreased 28.6 percent or 25.0 percent on a currency-neutral basis […]
Funding to Support U.S. Pivotal Trial of CLAAS® Stroke Prevention Technology NASHUA, N.H., Aug. 6, 2020 /PRNewswire/ — Conformal Medical, Inc., a medical device company focused on reducing stroke in patients with atrial fibrillation (AFib), today announced it has secured $85 million in Series C financing. The financing syndicate included participation from new investors Fidelity Management […]
EDEN PRAIRIE, Minn., Aug. 04, 2020 (GLOBE NEWSWIRE) — CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the second quarter ended June 30, 2020, which included the following highlights: Revenue for the second quarter ended June 30, 2020, was $1.9 million, an increase of 14 percent from the […]
The Series A, led by a non-disclosed strategic investor, together with Hadean Ventures and Investinor, will fund CardioMech’s journey to treat patients in a first-in-human feasibility trial MINNEAPOLIS, Aug. 5, 2020 /PRNewswire/ — Minneapolis based CardioMech AS, a medical device company developing a transfemoral, transseptally delivered mitral valve repair technology, announced today it […]
BRISBANE, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), today reported financial results for the second quarter ended June 30, 2020. “The second quarter of 2020 was one of incredible progress across our R&D pipeline, including the exciting new data from our danicamtiv program highlighting its unique […]
WARREN, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious diseases, today provided a clinical program update and reported financial results for the second quarter ended June 30, 2020. “Bellerophon has […]
In the second quarter the Company was granted approval to market its CGuard™ MicroNet stent in Brazil and completed an $11.5 million capital raise; reported outstanding results in studies treating patients with the CGuard™ MicroNET stent Management to host investor conference call today, August 5, 2020 at 8:30am ET TEL AVIV, […]
